Daryl Wiesen, a partner in Goodwin Procter’s IP Litigation Group, focuses his practice on patent litigation and advising clients in patent portfolio development. He has more than 15 years of experience advising clients and participating in all phases of patent litigation, from initial counseling up through trial and appeal. Mr. Wiesen has developed an expertise in pharmaceutical patent litigation under the Hatch-Waxman Act, representing both plaintiffs and defendants. He also has experience in other technologies, including biotechnology and medical devices. He represents universities in patent and licensing disputes concerning technology discovered at the universities and then out-licensed to companies for further development.

Mr. Wiesen has been named “Outstanding IP Litigator Massachusetts” for 2016 by Managing IP and has also been named a “Life Sciences Star” in the IP practice area by Euromoney’s LMG Life Sciences Guide. He has been honored with Goodwin’s Robert B. Fraser Pro Bono Award for his substantial pro bono work, including helping to obtain the freedom of a wrongfully convicted death row inmate in Ohio.

Experience

Erfahrung

工作经历

Mr. Wiesen devotes a substantial amount of his practice to patent litigation. He has recently represented:

Pharmaceutical Clients

  • Cephalon in patent litigation concerning its cancer treatment Treanda (Bendamustine). After a bench trial, the United States District Court for the District of Delaware found the asserted patents valid and infringed.  (Lead Trial Counsel)
  • Teva Pharmaceuticals and Fresenius Kabi USA, LLC in patent litigation concerning Eli Lilly’s antifolate cancer treatment pemetrexed (Alimta®). The case is currently under submission at the Federal Circuit. (Lead Trial Counsel)
  • Teva Pharmaceuticals in patent litigation concerning the new dosing regimen of Teva’s blockbuster Copaxone®. The case is currently under submission to the United States District Court for the District of Delaware. (Trial Counsel)
  • Fresenius Kabi USA, LLC in patent litigation concerning its branded parenteral anesthetic, Diprivan®. (Lead Trial Counsel)
  • Epocal, Inc. in patent litigation against Abbott Point of Care, Inc. concerning point of care blood testing devices. Abbott brought two lawsuits against Epocal in the Northern District of Alabama. In the first, the jury rendered a verdict of non-infringement on all asserted claims. In the second, the District Court dismissed the complaint for lack of standing, and the Federal Circuit affirmed the dismissal. (Trial and appellate counsel)
  • Teva Pharmaceuticals in patent litigation concerning its blockbuster innovative treatment for multiple sclerosis, Copaxone®. Teva prevailed on all nine patents asserted at the trial court in June 2012 and the Federal Circuit affirmed the judgment in 2013 as to four of the asserted patents. The case was subsequently appealed to the United States Supreme Court, resulting in a victory for Teva on the standard of review in claim construction in Teva v. Sandoz. (Trial and appellate counsel)

University Clients

  • Massachusetts Institute of Technology in litigation with Alnylam, Inc. and the Max Planck Institute concerning ownership and prosecution of the Tuschl patent portfolio, seminal patents directed to technology related to the development of RNAi therapeutics. Alnylam and Max Planck filed suit in the District of Massachusetts in 2009. The case was settled on favorable terms. (Lead counsel)
  • Massachusetts Institute of Technology and Children’s Medical Center (Boston) in patent litigation against Shire Regenerative Medicine concerning Shire’s Dermagraft product. Secured a favorable disposition at the district court and successfully defended the matter on appeal to the Federal Circuit. (Lead and appellate counsel)
Professional Activities

Mr. Wiesen is a member of the Boston and Massachusetts Bar Associations. He provides pro bono services for a variety of clients, including helping to obtain the freedom of a wrongfully convicted death row inmate in Ohio. He is a member of the Board of Directors for the Massachusetts Civil Liberties Union, the Massachusetts affiliate of the ACLU.

Recognition

Mr. Wiesen has been named “Outstanding IP Litigator Massachusetts” for 2016 by Managing IP. For four consecutive years Mr. Wiesen has been named a “Life Sciences Star” for IP by LMG Life Sciences, which recognizes the preeminent life sciences practitioners in the United States. Mr. Wiesen has also been recognized for several consecutive years by Intellectual Asset Managementin its “Patent 1000” publication and Managing IP in “IP Stars”.

While in law school, Mr. Wiesen was a senior editor of the Yale Law Journal and author of “Following the Lead of Defamation: A Definitional Balancing Approach to Religious Torts.”

In The News

In den Nachrichten

在新闻中

Credentials

Anmeldeinformationen

专业资格

Education

J.D., 1996
Yale Law School
B.A., 1993
Brown University

(magna cum laude, Phi Beta Kappa)

Clerkships

1996 to 1997 U.S. District Court for the District of Massachusetts, Honorable Reginald C. Lindsay

Admissions

Bar

Massachusetts

Courts

U.S. Supreme Court
U.S. District Court for the District of Massachusetts
U.S. Court of Appeals for the Federal Circuit
Get In Touch
In Kontakt kommen
Get In Touch
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
Suche Andere Rechtsanwälte
搜寻其他律师